Abbreviations: Gal, galactose-α1,3-galactose; GTKO, α1,3-galactosyltransferase gene-knockout; hCD46, human complement-regulatory protein CD46; PBMC, peripheral blood mononuclear cells.
| INTRODUCTION
Some patients with acute or acute-on-chronic hepatic failure will die before a suitable human liver allograft becomes available. Encouraging results have been achieved in such patients by the transplantation of human hepatocyte progenitor cells from fetal liver tissue into the spleen.
1 These cells have contributed toward the maintenance of life until a liver allograft has become available.
Human fetal tissue-derived hepatocytes may not be available in the numbers required to treat a large number of patients. Hepatocytes from genetically engineered pigs are an alternative source that could be unlimited. There is considerable evidence from the literature that hepatocytes from one species function in another. 2 Progress in the field of both hepatocyte allotransplantation and xenotransplantation has recently been reviewed. [3] [4] [5] [6] [7] [8] Hepatocytes from wild-type pigs have been reported to be resistant to complement-mediated injury, 9 and capable of producing pig proteins when transplanted into immunosuppressed monkeys. The genetic engineering of these pigs renders their cells no more immunogenic than their human counterparts. 10, 11 The present study was aimed to test the hypothesis that genetically engineered pig hepatocytes would function in baboons and would be relatively non-immunogenic.
Based on preliminary clinical experience of fetal hepatocyte allotransplantation, 1 the spleen was selected as the primary site for transplantation. Additional sites included (i) lymph nodes (based on encouraging results in rodent models from our center and others, [12] [13] [14] [15] (ii) the subcapsular space of the kidney, 16 and (iii) the subcutaneous fat of the abdominal wall.
17
The aim of the study was to explore survival of hepatocytes from genetically engineered pigs after transplantation into the spleen (via direct injection into the splenic pulp) and other selected sites of immunosuppressed baboons to monitor the immune response and the metabolic function and survival of the transplanted hepatocytes.
| MATERIALS AND METHODS

| Animals
Baboons (Papio species, n=3; Division of Animal Resources, Oklahoma
University Health Sciences Center, Oklahoma City, OK, USA), 3-4 years old, weighing 7-9 kg and of known AB blood type, were recipients of pig hepatocytes (n=3). The baboons were housed in an environmentally controlled room to which they were acclimated for at least one month before any experimental procedures. They had free access to food and water and were provided with social enrichment. In addition, for preliminary studies, portions of liver were obtained from deceased wild-type (genetically-unmodified) pigs through a local slaughterhouse and used to establish the hepatocyte isolation method.
| Excision of GTKO/hCD46 pig livers
Under full anesthesia, a midline abdominal incision was made in the pig to expose the liver. The pig was fully heparinized (300 IU/kg), and the hepatic artery (through the abdominal aorta) and portal vein were flushed with cold (4°C) Dulbecco's PBS (without calcium and magnesium, but including 1 mm Na-EDTA and antibiotic-antimycotic) (Thermo Fisher Scientific, Waltham, MA, USA). A hepatectomy was carried out.
| Pig hepatocyte isolation
A five-step perfusion of the pig liver was performed with modifications adapted from Gerlach et al. [21] [22] [23] [24] The liver was perfused ex vivo for 10 min at 37°C with 1L DPBS (without calcium and magnesium, grafts, or islets? (iii) Does injection of pig cells (antigens) into the spleen and/or lymph nodes stimulate a greater immune response than when pig tissues are grafted at other sites? (iv) Did the presence of the recipient's intact liver prevent survival and proliferation of pig hepatocytes? (v) Is pig CD47-primate SIRP-α compatibility essential? In conclusion, the transplantation of genetically engineered pig hepatocytes into multiple sites in immunosuppressed baboons was associated with very early graft failure.
Considerable further study is required before clinical trials should be undertaken.
K E Y W O R D S
baboon, hepatocytes, pig, xenotransplantation but including 2 g/L sodium bicarbonate, 2 g/L glucose, and antibioticantimycotic) (100 units/mL penicillin, 100 μg/mL streptomycin, 0.25 μg/mL amphotericin B), followed by perfusion at 37°C with 1L of 
| Pig hepatocyte transplantation in baboons
Under full anesthesia, a midline abdominal incision was made. Pig hepatocytes (suspended in cold William's Medium E) were injected directly into four sites: (i) the parenchyma of the lower pole of the spleen, (ii) the subcapsular space of one or both kidneys, (iii) three mesenteric lymph nodes (and in Baboon 3 into a femoral lymph node through a small incision over the node), and (iv) the adipose tissue of the anterior abdominal wall (through the midline incision), all using an 18-gauge needle. The sites and numbers of injected hepatocytes in each baboon are shown in Table 1 . Postoperative analgesia was with buprenorphine 0.01 mg/kg i.m. ×2 daily for 3 days.
In Baboon 3, the femoral lymph node was excised on posttransplant day 7 (under full anesthesia) to determine the early survival of the injected pig hepatocytes.
| Immunosuppressive and supportive therapy
All three baboons received anti-thymocyte globulin (ATG) induction and tapering methylprednisolone ( Table 2) . Baboon 1 received maintenance immunosuppressive therapy with tacrolimus and rapamycin.
Whole blood levels of tacrolimus and rapamycin were measured at least ×2 weekly and remained largely within the desired ranges ( Table 2) .
Baboons 2 and 3 received an anti-CD40mAb/rapamycin-based regimen that prevents sensitization (ie, an anti-pig IgM and IgG antibody response and a T cell proliferative response) to pig heart, kidney, and artery patch transplants in baboons. [25] [26] [27] The anti-CD40mAb (2C10R4) was kindly provided by Dr. Keith Reimann at the NIH NHP Resource
Center, Boston, MA. The levels of 2C10R4 were not measured, but previous studies by us and others have indicated that, at the dose used, the levels were higher than those considered in the therapeutic range. 
| CFSE-mixed lymphocyte reaction (MLR)
Blood was drawn for CFSE-mixed lymphocyte reaction (MLR) to determine the baboon's cellular proliferative response, as previously described 31 (i) before any immunosuppressive therapy was administered and (ii) between days 28 and 35 (before euthanasia).
| Monitoring for hepatocyte survival and function
At the time of euthanasia, samples were taken from the sites of hepatocyte transplantation for (i) real-time PCR detection of porcine DNA and (ii) real-time PCR for porcine gene expression. Pig albumin levels were measured in the baboon blood by pig albumin ELISA, using the method of Nagata et al. 32 
| DNA and RNA extraction
DNA and RNA were extracted using the AllPrep DNA/RNA mini kit (Qiagen, Hilden, Germany) from frozen tissue pieces that were snap-frozen in liquid nitrogen immediately after excision. Tissues were homogenized in RLTplus buffer using a TissueRuptor and subsequently lysed using QIAshredder columns (all Qiagen). DNA and RNA were simultaneously extracted from the same samples;
RNA was treated with DNase (Qiagen) on extraction columns.
Concentrations of eluted nucleic acids were determined with a
Qubit fluorometer using Quant-iT dsDNA and RNA assay kits (Thermo Fisher Scientific).
| Real-time PCR for detection of porcine DNA
Porcine DNA in baboon samples was quantified using Taqman 
| Detection of pig albumin in baboon sera by enzyme-linked immunosorbent assay (ELISA)
The pig albumin concentration in the baboon blood was measured 
| Histopathological examination
At the time of euthanasia (28-35 days), biopsies of the spleen, mesenteric lymph nodes, kidneys, and anterior abdominal wall fat were taken for histological examination for the presence of pig hepatocytes (and DNA). Biopsies were stored in formalin and OCT for immunostaining, and snap-frozen for mRNA. All major organs were inspected for signs of pathology, and, if present on macroscopic examination, biopsies were taken for microscopic examination.
In addition, in Baboon 3 the single femoral lymph node injected with pig hepatocytes was excised on day 7 for histological examination.
| RESULTS
| Isolation of GTKO/CD46 pig hepatocytes
The isolation of pig hepatocytes from GTKO/hCD46 pig livers proved straightforward.
The isolated hepatocytes were examined by immunofluorescence and flow cytometry for expression of Gal, SLA I, SLA II, and hCD46.
They expressed no Gal, but high levels of hCD46 (not shown 
| Pig hepatocyte transplantation in immunosuppressed baboons
| Recipient baboon survival and clinical complications
All three baboons remained healthy and active throughout the period of follow-up which was electively for either 28 (n=2) or 35 (n=1) days (Table 1 ). There were no complications from the surgical procedure or immunosuppressive therapy. 
| Immunologic monitoring
| Monitoring for hepatocyte survival and function
Real-time PCR for detection of porcine DNA Very low levels or no pig DNA were detectable in any of the baboon tissues tested (Table 3 ). The femoral lymph node examined 7 days after the hepatocyte injection showed a relatively high percentage of pig DNA, but levels in all other tissues at 4 or 5 weeks were very low, except on one occasion. (The high expression in one mesenteric lymph node at 4 weeks in Baboon 1 cannot be explained.) In Baboon 2, that had no detectable immune response to the pig hepatocytes and the levels of pig DNA were particularly low.
Real-time PCR for detection of pig gene expression
Pig gene expression in the baboon tissues was equally low (Table 4) , and correlated fairly well with the detection of pig DNA. In the majority of the tissues, no pig gene expression was detected.
Detection of pig albumin in baboon sera by ELISA
No pig albumin was detected in baboon sera before transplantation.
After hepatocyte transplantation, pig albumin was detected at every time-point, but at very low levels ( Figure 3 ). Baboon 1 demonstrated the highest pig albumin concentration at 1 week after transplantation, but the level then slowly decreased. Baboons 2 and 3 had even lower levels, with peak levels at 3 and 2 weeks, respectively. The results were compared with those from historic baboons with pig orthotopic liver grafts (n=3, Baboons 4-7) on day 3 post-transplant, which were several hundred-fold higher, and with levels from healthy pigs (n=2, Pigs 1 and 2), that were approximately 5-10-fold higher than in baboons with orthotopic pig liver grafts and >5000-fold higher than in baboons with pig hepatocyte transplants. 
| Histopathology
| DISCUSSION
Pig hepatocyte isolation proved straightforward from livers of GTKO/ hCD46 pigs. However, even with the transplantation of hepatocytes from pigs genetically engineered to provide some protection from the primate innate immune response, 34 the results were extremely disappointing.
In all 3 baboons, there was minimal or no evidence of pig DNA or pig gene expression at any of the sites of hepatocyte injection, and minimal pig albumin was detected in the blood of the baboons.
Because the half-life of endogenous albumin is approximately 3 weeks, while that of blood-derived albumin is only 12-16 h, 35 we anticipated that a significant level of pig albumin would be detected in the recipient at least for one day after transplantation. However, the levels of albumin measured were many 100-fold less than detected in baboons with orthotopic liver grafts 36 and many 1000-fold less than in healthy pigs. Despite our opinion based on in vitro studies that the isolated hepatocytes were viable, our failure to carry out functional studies in rodents means that we cannot exclude the possibility of inadequate engraftment.
However, immune assays demonstrated that Baboons 1 and 3 became sensitized to pig antigens (increase in anti-pig IgG in both cases and T cell proliferative response in Baboon 1). In these two baboons, the grafts may well have been lost from an immune response (although no features were seen on histopathological examination at the sites of transplantation). In Baboon 1, the immunosuppressive regimen was clearly inadequate, but in Baboons 2 and 3 we had administered a costimulation blockade-based immunosuppressive regimen that has repeatedly been demonstrated to prevent a response to pig antigens after pig heart, kidney, and artery patch transplants in baboons that have been followed for up to 5 months. [26] [27] [28] Furthermore, it prevented an anti-pig IgG response in Baboon 2.
The response documented in Baboon 3 may have been associated with the site of transplantation (ie, spleen or lymph node versus direct blood vessel anastomosis in the abdomen) or to the immunogenicity of the transplanted tissue (ie, hepatocytes versus organ). Transplantation of allogeneic hepatocytes into lymph nodes in immunosuppressed mice has been successful. 12, 13 An alternative factor may have been that Matrigel (a mouse tumorderived extracellular protein extract) may not be as effective as the alginate (an algae-based polysaccharide) used by Nagata et al. 32 However, this specific alginate preparation does not appear to be available today, and the alternate alginate preparations we tested to create gels became solid once calcium was added (which is essential) and could not be used for injection. However, the Matrigel we used has been shown to be effective in mouse hepatocyte and multiple other cell studies. All biopsies were taken at 4 or 5 weeks after pig hepatocyte transplantation, except for one femoral lymph node biopsy in Baboon 3, which was examined after one week. Baboon tissues were analyzed for porcine DNA; data are given as means from 3 technical repeats as percentage of porcine DNA of the total DNA. All biopsies were taken 4 or 5 weeks after pig hepatocyte transplantation, except for one femoral lymph node biopsy in Baboon 3, which was examined after one week. Baboon tissues were analyzed for porcine gene expression by real-time PCR; data are presented as means from three technical repeats in percentage of porcine liver cDNA. AFP, alpha-fetoprotein.
In Baboon 2, one reason for the disappointing result might have been because the hepatocytes had not been administered in a gel, as reported by Nagata et al. 32 This may have resulted in rapid loss of hepatocytes from the sites of injection. In Baboon 3, therefore, we injected the hepatocytes in Matrigel. Furthermore, we injected the pig hepatocytes into an additional site (a femoral lymph node) and examined this lymph node for the presence of pig hepatocytes after one week, in addition to the usual examination of all sites at 4 or 5 weeks.
In Baboon 3, at one week, the femoral lymph node demonstrated higher levels of pig DNA and gene expression than seen previously (at 4 weeks). Disappointingly, however, the results at 5 weeks were again almost identical to those in Baboons 1 and 2, with minimal evidence of pig hepatocyte survival, and minimal albumin levels in the blood.
However, this prolonged exposure to the pig antigens may have increased the likelihood of sensitization.
As a result of this disappointing experience, the following points need to be considered. 
3.
Did the presence of the recipient's intact liver (with a full complement of hepatocytes) prevent survival and proliferation of pig hepatocytes (probably related to the absence or low levels of factors that stimulate hepatocyte growth). We suggest that this may be an important factor. 15 Future studies should investigate pig hepatocyte transplantation in non-human primates that are in hepatic failure (eg, after partial hepatectomy, portal vein embolization 37, 38 and injury to the remaining hepatocytes). In Nagata's study, 18 no steps were taken to reduce the hepatocyte mass or function of the native liver, and so this was not a major difference from our own study. As the outcome of Nagata's study was significantly better than ours, this suggests that rendering the recipient in hepatic failure may not be essential.
4.
Is compatibility between pig CD47 and primate SIRP-α essential if phagocytosis of the hepatocytes is to be avoided? As porcine hepatocytes (20-30 μm) 39 and primate macrophages (20-50 μm) are of similar size, we suggest that the hepatocytes are too large to be phagocytosed by the macrophages. However, fragile hepatocytes could fragment, possibly from direct activation of recipient macrophages resulting in injury to the hepatocytes, 40 and then be phagocytosed. In addition to the evidence of CD47/SIRP-α species incompatibility, [40] [41] [42] natural killer (NK) cells can affect xenograft survival in mice through NK cell-mediated cytotoxicity. Furthermore, in the Nagata study, the period of time from hepatocyte isolation to transplantation was approximately 20 h, whereas in our study this was <60 min.
In Nagata's study, 32 graft function was determined by the measurement of porcine albumin. A peak of porcine albumin was detected in the blood within the first month. Following a single injection, the pig hepatocytes functioned for between 25 days (limited by death of the monkey from a cytomegalovirus infection) and >80 days. Following retransplantation on two occasions in one of the monkeys, porcine albumin was detected for >253 days (the monkey dying from complications associated with replacement of a central venous catheter). Although pig hepatocyte transplantation was associated with a slight increase in anti-Gal IgG (considered to be within the normal range), there was no detectable increase in anti-non-Gal antibody levels, suggesting that the transplantation of F I G U R E 3 Pig albumin levels in the sera of baboons with GTKO/hCD46 pig hepatocyte transplants. Some pig albumin was detected in the serum of all 3 baboons, but the levels were very low. Also shown are levels in the sera of two healthy GTKO/hCD46 pigs (Pigs 1 and 2) and in the sera of 3 baboons on day 3 after pig orthotopic liver transplantation (Baboons 4, 5, and 6). 29 Following pig hepatocyte transplantation, the pig albumin levels were approximately 500-1000-fold less than in baboons with pig liver grafts, and approximately 5000-10 000-fold less than in healthy pigs hepatocytes from GTKO pigs might induce a minimal humoral immune response. We could not confirm this hope in the present study.
It may be that transplantation into the spleen alone is not immunogenic, but that transplantation in other sites, eg, lymph nodes, might be, although the similarities in structure and function between spleen and lymph nodes suggest that this is unlikely.
From experience gained from the present study, if initiating further studies, we would make the following changes to the experimental protocol. We would (i) carry out functional studies in rodents to confirm the functional viability of the hepatocytes, (ii) inject the hepatocytes into just one site, eg, spleen, in case injection into other sites might be detrimental (as it is possible that hepatocytes injected into some sites are more immunogenic than others, and this might confuse the results), (iii) measure the cytokine and chemokine responses to the hepatocytes as an indicator of the innate immune response, and (iv) consider the transplantation of pig hepatocytes expressing human CD47 and/or HLA-E/G, 47, 48 as this might be beneficial in reducing the innate immune response. Based on our pig liver transplants into baboons ( Figure 3 ), 36 we suggest that a minimal functional level of albumin might be at least 500 mg/dL, but preferably >1 g/dL.
In conclusion, the transplantation of genetically engineered pig hepatocytes into multiple sites in immunosuppressed, but otherwise healthy, baboons was associated with very early graft failure even in the absence of an adaptive immune response. Considerable further studies are required before clinical trials should be undertaken. and to Matthew Young for assistance during ex vivo liver perfusion.
ACKNOWLEDGMENTS
